Nurix Therapeutics (NRIX)

Nurix Therapeutics (NRIX) stock research: performance, analysts' price targets, earnings, revenue and margins, technicals and insider trades.

• NRIX last traded at $25.78, -3.81% on the day.
• Nurix Therapeutics: P/E 10.3, revenue $701.94M over the last four quarters.
• Over the past year NRIX returned 101.72%; year to date 35.90%.

Updated 2026-11-02 17:50 UTC